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Abstract: A low-cost, in vitro laboratory experiment has been developed that mimics the 
absorption of a pharmaceutical drug in the body. It allows undergraduate chemistry students 
to gain experience in the measurement of drug permeability coefficients, a key indicator used 
by the pharmaceutical industry to identify the ease of absorption of any new drug candidate. 
The experiment requires a diffusion cell, coated membrane, peristaltic pump and UV-Vis 
spectrophotometer. The method has been validated by determining the permeability 
coefficients for a selection of acidic, basic and non-ionizable drugs. Using this assay, it is 
possible to classify drugs as exhibiting high or low permeability in a fast, facile and reliable 
manner. 
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Introduction 
 
The discovery and development of a modern pharmaceutical drug, from original design 
through clinical trials to marketing, is both lengthy and costly. Many, initially promising, 
drug candidates fail because of poor absorption in the body. To be absorbed easily, a drug 
needs to dissolve under physiological conditions, as well as be able to permeate through a 
non-polar membrane barrier upon passing from the intestine into the blood stream. Due to the 
importance of this factor, the pharmaceutical industry nowadays routinely conducts a series 
of physicochemical assays (e.g. determination of pKa, lipophilicity, solubility and 
permeability) during the initial stages of the drug development process so that any potential 
problems with absorption may be identified early [1].  
One of the most promising in vitro permeation assays reported to date is the parallel 
artificial membrane permeability assay (PAMPA) proposed by Kansy et al. in 1998. It probes 
the ability of a drug to permeate through a lipid-coated artificial membrane (around 0.2 mm 
thick) from a donor to an acceptor compartment [2]. PAMPA is an alternative to the 
permeability screens based on Caco-2 colon cancer cell lines, which have the disadvantage of 
being both costly and time-consuming [3,4]. Being designed for high-throughput screening, 
PAMPA has the potential to examine several drugs simultaneously and at varying pH in a 
single experiment through the use of a 96-well microtitre plate. Putting these advantages 
aside, the original PAMPA procedure suffers from a significant limitation due to the presence 
of an unstirred water layer surrounding the membrane; this can lower a drug’s permeability 
by several orders of magnitude and is responsible for long assay times. However, it has 
recently been reported that efficient magnetic stirring during the permeability measurement 
can substantially reduce the unstirred water layer, from 2 – 4 mm (unstirred) to less than 0.1 
mm when stirred at high speed [5,6,7]. Stirring was also found to widen the gap between 
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high-permeability drugs, which can have a permeability coefficient of up to 10–2 cm s–1, and 
low-permeability drugs (where the permeability coefficient is 10–6 cm s–1) as well as 
dramatically reduce the time needed to perform a permeability experiment, from normally 18 
hours to just 1 – 2 hours for highly permeable drugs. PAMPA has further gained in 
importance since FDA and its European counterparts have started to consider a biowaiver and 
fast-track the approval of certain drugs that have been found in in vitro tests to be clearly both 
highly soluble and highly permeable (Class I drugs according to the Biopharmaceutics 
Classification System) [8].  
Despite the success of PAMPA in the pharmaceutical industry, permeability 
measurements are rarely performed outside big companies and specialist research labs. There 
can be little doubt that students specialising in pharmaceutical or medicinal chemistry need to 
be provided with more hands-on experience in determining important physicochemical 
properties. Recent examples in educational journals included experiments for determining 
ionization constants [9], octanol–water partition coefficients [10] and performing dissolution 
tests [11,12] on common pharmaceutical drugs. Permeability assays, however, have received 
little attention in undergraduate teaching labs. In this paper, we describe a simple procedure 
for measuring permeability coefficients of pharmaceutical drugs with the help of a diffusion 
cell, a peristaltic pump and a UV-Vis spectrophotometer. Such equipment is available in most 
teaching labs or is affordable on a limited budget. The experiment mimics the way drugs are 
absorbed in the body, which allows students to learn and understand what happens following 
oral administration of a medicine. Finally, the method has been validated by determining the 
permeability coefficients for a selection of acidic, basic and neutral drugs and comparing the 
results afforded with those published in the literature.  
 
Experimental Section 
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Apparatus for Measuring Drug Permeability. All permeability experiments were 
carried out in a vertical diffusion cell. The 100 mL diffusion cell was made in-house from 
glass and standard flat flanges with a 35 mm bore. A typical set-up is shown in Figure 1. The 
donor compartment of the diffusion cell was filled with a 0.15 – 0.5 mM drug stock solution 
in a suitable buffer. The acceptor compartment contained a pH 7.4 phosphate buffer adjusted 
with KCl to an ionic strength of 0.15 M (this solution mimicked blood in both pH and ionic 
strength). The two compartments were separated by a mixed cellulose ester membrane 
(Millipore MF, 0.025 m pore size, 70% porosity, 105 m thickness, 47 mm diameter) which 
had been coated with a 2% solution of phosphatidyl choline in hexadecane [5]; the lipid-
coated membrane served as a model for the lining of the stomach or intestine. The side arm of 
the diffusion cell allowed a drug stock solution to be added, the pH to be adjusted or samples 
to be taken from the donor compartment.      
Permeability Measurement Procedure. The donor compartment of the diffusion cell 
was filled with drug stock solution (63 mL) through the side arm. The diffusion cell was 
immersed in a water bath thermostated at 37 ± 1 °C. The pH of the drug stock solution was 
adjusted by dispensing 0.5 M aqueous NaOH or 0.5 M aqueous HCl. The experiment started 
upon addition of pH 7.4 buffer solution (20 mL) to the acceptor compartment of the diffusion 
cell. To minimize the size of the unstirred water layer, the donor solution was magnetically 
stirred at 620 rpm (which is the maximum setting for this equipment) throughout the duration 
of the experiment. A peristaltic pump circulated the acceptor solution, at a flow rate of 75 mL 
min–1, to a UV flow cell and back. Typically 10 UV spectra (210 – 400 nm) of the acceptor 
solution were recorded every 3 minutes over a period of 30 minutes. Both the donor and 
acceptor solutions were replaced before the start of a new experiment. 
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Analysis of Permeability Data. The change in absorbance (or concentration) in the 
acceptor compartment, CA(t), with time t was fitted to a generic exponential curve 
     01 Aktmax,AA CeCtC     (1) 
using a non-linear least squares procedure [13] and three fitting parameters, CA,max, CA(0) 
and k. CA,max represents the extrapolated maximum concentration (absorbance) of the drug in 
the acceptor compartment, CA(0) the initial drug concentration (absorbance) at the start of the 
experiment, and k is formally a permeation rate constant. At time t = 0, the slope of the 
generic exponential curve is readily obtained by differentiation of Equation 1 and equals k  
CA,max. The apparent permeability coefficient, Papp, of the drug is directly proportional to this 
“initial slope” and calculated according to Equation 2  
)(AC
VkC
P
D
Amax,A
app 0
  (2) 
where A is the effective area of the coated membrane (6.7 cm2) and VA the volume of the 
acceptor compartment (20 mL). The initial drug concentration (absorbance) in the donor 
solution, CD(0), was determined by recording a reference UV spectrum of the drug stock 
solution.   
In practice, the order of magnitude of the permeability coefficient is generally more 
important and, therefore, log Papp was considered instead (Equation 2a). 

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logPlog
D
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 (2a) 
Log permeability vs. pH plots were fitted by a non-linear least squares procedure to 
Equation 3 [5,14]  
 


   110 pHpKmaxapp
flux
alogPlogPlog  (3) 
where pKaflux is the aqueous ionization constant under permeability or flux conditions 
and log Pmax is the logarithm of the maximum permeability coefficient where the curve levels 
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off. A positive sign in the exponent is required for bases and a negative sign for acids. Both 
pKaflux and log Pmax served as fitting parameters.  
 
Results and Discussion 
 
Permeability experiments were carried out in a diffusion cell consisting of a donor 
compartment (containing the drug stock solution) and an acceptor compartment (containing 
pH 7.4 buffer at the same ionic strength as blood) separated by a lipid-coated commercial 
membrane (Figure 1). Drug concentrations selected for use in the donor compartment ensured 
that a single permeability test was completed in about 30 minutes. The pH 7.4 buffer solution 
in the acceptor compartment was circulated through a UV flow cell and back. The UV-Vis 
spectrophotometer was programmed to record a UV spectrum (210 nm – 400 nm) every 3 
minutes and save the spectra for later data analysis. Alternatively, the change in drug 
concentration with time was followed by recording the change in absorbance at a single 
wavelength.  
We chose the drug naproxen for our first model permeability study since this drug has 
been studied extensively in a variety of permeability assays and is well known to be highly 
permeating. Naproxen is a weak acid, with a pKa of 4.18, and has a strong absorption 
maximum at 229 nm and a weaker absorption at 264 nm. At low pH, naproxen is in its 
neutral form which makes it easy for the molecules to permeate a non-polar membrane, be it 
a cell membrane or a lipid-coated artificial membrane. However, with increasing pH, 
naproxen becomes more and more ionized, which improves its aqueous solubility but reduces 
its permeability. When tested in our diffusion cell set-up, naproxen was found to permeate 
quickly from the donor compartment through the coated membrane into the acceptor 
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compartment; this was readily apparent by observation of an increase in the corresponding 
absorbance peak at 229 nm with time in the UV spectra recorded of the acceptor solution.  
Like a standard diffusion process [15], with which students should be familiar from 
physical chemistry lectures, the permeation of a drug through a membrane under steady-state 
conditions can be described by Fick’s first law (Equation 4) 
 AD
A
appA CC
V
AP
dt
dC   (4) 
The solution for this differential equation is an exponential function. Figure 3 shows how the 
absorbance at 229 nm changed over time at three representative pH values. At pH 3.0, the 
plot had a characteristic exponential shape and absorbance readings started to approach a 
maximum value within half an hour. The data could be fitted to a generic exponential curve 
(Equation 1). However, at pH 4.3, the permeability of naproxen was not only lower but the 
curve’s shape became almost a straight line with a reduced slope. When the pH of the donor 
solution was raised to 5.3 or higher, the gradient decreased even further. Although the curve’s 
exponential shape was no longer evident at increased pH, the apparent permeability could 
still be calculated from the initial gradient observed during a 30 minute experiment.  
For ionizable drugs, the permeability coefficient depends on the pH of the donor solution 
and it is therefore important that this parameter is evaluated over an appropriate pH range. In 
the case of a weakly acidic drug, such as naproxen, the pH of the donor solutions selected for 
evaluation typically covered the range from 3 to 6. Figure 4 shows the “log permeability 
versus pH profile” obtained for naproxen and it is characteristic of a weak acid. At low pH, as 
the drug was in its neutral form, log Papp was at its highest value (log Pmax). However, upon 
steadily increasing the pH of the donor solution, a point was eventually reached where the 
value deduced for log Papp began to decrease; this happened above naproxen’s pKaflux, the 
aqueous ionization constant under flux conditions where 50% of the drug was in its ionized 
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form [3]. The pKaflux differs from the aqueous pKa due to the partitioning of the ionizable 
drug between the aqueous solution and the lipophilic coating of the membrane [3,16]. 
Whereas weakly acidic drugs were found to permeate most easily at low pH, the 
maximum permeability coefficient (log Pmax) for a weak base such as propranolol was 
reached instead at high pH (Figure 5a). Non-ionizable drugs (e.g. nifedipine) showed, as 
expected, virtually no variation in their log Papp values as a function of pH, over the wide 
range explored (Figure 5b).  
The maximum permeability coefficients that could be determined using our diffusion cell 
procedure were, for the majority of cases, similar to or slightly smaller than those reported in 
the literature, which had been obtained using a PAMPA assay where the donor compartment 
was stirred. More examples are included in the Supporting Material. Minor deviations were 
attributed to the lower stirring efficiency in our method. From one operator to another, log 
Papp values could be reproduced within 0.3 (see Supporting Material). It has been estimated 
that the lower limit for log Papp that can be successfully determined using our approach is 
about –4 to –5, provided that the drug has a sufficiently strong UV absorbance.  
To date, this experiment has been performed by 11 advanced level students (2007 – 
2012) who worked alone and determined entire log permeability vs. pH profiles for selected 
drugs as part of their dissertation projects. In addition, three 16 to 17-year old pupils from 
local schools, who had applied through the Nuffield Science Bursary scheme for a placement 
for a summer project, have also helped testing the method. For adaption to an undergraduate 
teaching experiment, students could be asked to work in small groups and, rather than 
determine full log permeability vs. pH profiles, measure permeability for one drug only at 
selected pH values.  
 
Conclusions 
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This experiment provides students with an insight into how a drug is absorbed in the body 
and introduces the concept of permeability coefficients for pharmaceutical drugs. It does not 
rely on any specialized equipment and illustrates within 30 minutes whether a drug permeates 
rapidly at a certain pH or not. By curve fitting absorbance–time curves, students are able to 
determine the actual permeability coefficients for a range of drugs for themselves. The 
method works best for drugs with medium to high permeability (log Papp  –4). Like 
PAMPA, the diffusion cell method allows drugs to be categorized into low and high 
permeability compounds according to the Biopharmaceutics Classification System. 
Undoubtedly, the opportunity to obtain experience in this area will be of considerable benefit 
to chemistry students, particularly those who are interested in seeking future employment in 
the pharmaceutical sector.  
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Supporting Materials. Detailed experimental and analytical procedures, results for other 
drugs studied, discussion of reproducibility and scope are given in the supporting materials. 
Typical analysis spreadsheets for determining permeability coefficients and fitting “log 
permeability vs. pH profiles” are also provided (http://dx.doi.org/10.1333/...).  
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(pH 7.40, 0.15 M KCl)
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Figure 1. Schematic drawing of the set-up used for measuring drug permeability.   
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Figure 2. UV spectra of the acceptor solution recorded at set times (in seconds) during a 
typical permeability experiment using a naproxen donor solution at pH 3.0. 
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Figure 3. Plot of absorbance at 229 nm against time for naproxen at three different pH values 
(pH 3.0 – diamonds; 4.3 – squares; 5.3 – circles). The drawn curves represent the best fit of a 
generic exponential curve (Equation 1) through the data points. The initial gradient of the 
exponential curve at time t = 0 is shown for the curve fitted to the pH 3.0 data; from this, the 
logarithm of the permeability coefficient (log Papp) could be calculated using Equation 2a.   
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Figure 4. Plot of log Papp against pH for naproxen. The solid circles are experimental data 
points, whereas the drawn curve represents the best fit to Equation 3 with a log Pmax of –3.51 
and a pKaflux of 3.79. 
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Figure 5. Plots of log Papp against pH for (a) a basic drug (propranolol) and (b) a non-
ionizable drug (nifedipine). 
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